Task: Answer the multiple choice question.
Query: Which drug exhibits a -0.028% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) CCn1c(=O)c([N+](=O)[O-])c(NC2CCS(=O)(=O)C2)c2ccccc21
b) Cc1ccc(-c2nn(-c3ccccc3Cl)cc2C(=O)NCC2CCCO2)cc1
Answer: b. Cc1ccc(-c2nn(-c3ccccc3Cl)cc2C(=O)NCC2CCCO2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-c2nn(-c3ccccc3Cl)cc2C(=O)NCC2CCCO2)cc1
Cc1ccc(-c2nn(-c3ccccc3Cl)cc2C(=O)NCC2CCCO2)cc1
1-(2-chlorophenyl)-3-(4-methylphenyl)-N-(oxolan-2-ylmethyl)pyrazole-4-carboxamide